The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow
暂无分享,去创建一个
A. Simiczyjew | D. Nowak | G. Dworacki | E. Jaskuła | M. Mordak-Domagała | J. Lange | A. Lange | M. Sędzimirska | M. Mordak‐Domagała